Table 2.
Squamous Cell K. | CK5/6, CK7, EMA, GFAP |
Small cells K of the lung | CD56, CK7, TTF1, EMA |
Lung Adeno-K | CK7, TTF1, Napsin A, EMA, CAM 5.2, CEA, RCC (Variable) |
Breast Adeno-K | CK5/6 (Variable), CAM 5.2, CK7, GCDFP15, EMA, S100 (variable), CEA, CA 15-3 |
Endometrial K | CAM 5.2, CK7, CA 125, ER (variable), CA125, CEA |
Colorectal Adeno-K | CAM 5.2, CK20, CDX2, EMA, CEA, CA 19.9 |
Stomach Adeno-K | CAM 5.2, CK7, CK20, CDX2, EMA, CEA, CA 19.9 |
Prostate Adeno-K | PSA, EMA |
Urothelial K | CK5/6, CK7, CK20, EMA |
Renal cell K | RCC, EMA, PAX8, Vimentin |
Melanoma | Vimentin, Melan A, S100, HMB 45 |
K = carcinoma; Adeno-K= adenocarcinoma; CK = cytokeratin; EMA = epithelial membrane antigen; TTF1 = Thyroid transcription factor 1; PSA = prostate-specific antigen; RCC = renal cell carcinoma protein; CEA = Carcinoembryonic antigen; CA = carbohydrate antigen.